These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 7508338
1. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. Cancer Res; 1994 Feb 01; 54(3):805-10. PubMed ID: 7508338 [Abstract] [Full Text] [Related]
2. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Cancer Epidemiol Biomarkers Prev; 1998 May 01; 7(5):391-5. PubMed ID: 9610788 [Abstract] [Full Text] [Related]
3. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF. Clin Cancer Res; 2000 Mar 01; 6(3):901-8. PubMed ID: 10741714 [Abstract] [Full Text] [Related]
4. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Barreto AM, Schwartz GG, Woodruff R, Cramer SD. Cancer Epidemiol Biomarkers Prev; 2000 Mar 01; 9(3):265-70. PubMed ID: 10750664 [Abstract] [Full Text] [Related]
5. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O'Neill LP, Xu Y, Peehl DM, Stewart PM, Turner BM, Campbell MJ. Oncogene; 2004 Sep 02; 23(40):6712-25. PubMed ID: 15300237 [Abstract] [Full Text] [Related]
6. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells. Cramer SD, Peehl DM, Edgar MG, Wong ST, Deftos LJ, Feldman D. Prostate; 1996 Jul 02; 29(1):20-9. PubMed ID: 8685051 [Abstract] [Full Text] [Related]
9. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ, Peehl DM, Feldman D. Endocrinology; 1995 Jan 02; 136(1):20-6. PubMed ID: 7530193 [Abstract] [Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S, Krishnan AV, Feldman D. Clin Cancer Res; 2000 Aug 02; 6(8):3371-9. PubMed ID: 10955825 [Abstract] [Full Text] [Related]
18. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Peehl DM, Sellers RG. Exp Cell Res; 1997 May 01; 232(2):208-15. PubMed ID: 9168795 [Abstract] [Full Text] [Related]
19. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes. Park K, Bae H, Heydemann A, Roberts AB, Dotto GP, Sporn MB, Kim SJ. Cancer Res; 1994 Dec 01; 54(23):6087-9. PubMed ID: 7954451 [Abstract] [Full Text] [Related]
20. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. Campbell MJ, Reddy GS, Koeffler HP. J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]